RTHP-27. PHASE I/II STUDY OF DDFPe AS A RADIOSENSITIZER IN GLIOBLASTOMA

DISCUSSION:DDFPe is a promising oxygen therapeutic for reversing tumor hypoxia and merits Phase II study.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Unger, E., Mason, R., Zhou, H., Sellenger, M., Ruben, J., Lickliter, J., Longacre, O. Tags: RADIATION THERAPY Source Type: research